Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Bellone

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
European Journal of Immunology|November 18, 2006
Prolonged exposure of dendritic cells to maturation stimuli favors the induction of type-2 cytotoxic T lymphocytesAndrea Boni, Giandomenica Iezzi, Elena Degl'Innocenti, et al.
Cancer Research|March 30, 2013
Booster vaccinations against cancer are critical in prophylactic but detrimental in therapeutic settingsAlessia Ricupito, Matteo Grioni, Arianna Calcinotto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
The immunogenicity of dendritic cell-based vaccines is not hampered by doxorubicin and melphalan administrationAnna Casati, Valérie S Zimmermann, Fabio Benigni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2011
Modulators of arginine metabolism do not impact on peripheral T-cell tolerance and disease progression in a model of spontaneous prostate cancerNicolò Rigamonti, Giusy Capuano, Alessia Ricupito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 2012
Targeting TNF-α to neoangiogenic vessels enhances lymphocyte infiltration in tumors and increases the therapeutic potential of immunotherapyArianna Calcinotto, Matteo Grioni, Elena Jachetti, et al.
Frontiers in Immunology|November 27, 2020
Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and CancerArianna Brevi, Laura Lucia Cogrossi, Giulia Grazia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2018
Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell TherapyAngela Rita Elia, Matteo Grioni, Veronica Basso, et al.
Plos One|January 15, 2010
iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cellsMatteo Bellone, Monica Ceccon, Matteo Grioni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2011
Concurrent allorecognition has a limited impact on posttransplant vaccinationTeresa Manzo, Rodrigo Hess Michelini, Veronica Basso, et al.
Journal for Immunotherapy of Cancer|August 2, 2019
Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survivalCarlo Sorrentino, Zhinan Yin, Stefania Ciummo, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
European Journal of Immunology|November 18, 2006
Prolonged exposure of dendritic cells to maturation stimuli favors the induction of type-2 cytotoxic T lymphocytesAndrea Boni, Giandomenica Iezzi, Elena Degl'Innocenti, et al.
Cancer Research|March 30, 2013
Booster vaccinations against cancer are critical in prophylactic but detrimental in therapeutic settingsAlessia Ricupito, Matteo Grioni, Arianna Calcinotto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
The immunogenicity of dendritic cell-based vaccines is not hampered by doxorubicin and melphalan administrationAnna Casati, Valérie S Zimmermann, Fabio Benigni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2011
Modulators of arginine metabolism do not impact on peripheral T-cell tolerance and disease progression in a model of spontaneous prostate cancerNicolò Rigamonti, Giusy Capuano, Alessia Ricupito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 2012
Targeting TNF-α to neoangiogenic vessels enhances lymphocyte infiltration in tumors and increases the therapeutic potential of immunotherapyArianna Calcinotto, Matteo Grioni, Elena Jachetti, et al.
Frontiers in Immunology|November 27, 2020
Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and CancerArianna Brevi, Laura Lucia Cogrossi, Giulia Grazia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2018
Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell TherapyAngela Rita Elia, Matteo Grioni, Veronica Basso, et al.
Plos One|January 15, 2010
iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cellsMatteo Bellone, Monica Ceccon, Matteo Grioni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2011
Concurrent allorecognition has a limited impact on posttransplant vaccinationTeresa Manzo, Rodrigo Hess Michelini, Veronica Basso, et al.
Journal for Immunotherapy of Cancer|August 2, 2019
Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survivalCarlo Sorrentino, Zhinan Yin, Stefania Ciummo, et al.
Pageof 9